Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2005-09-06
2005-09-06
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S283000, C514S449000, C514S274000, C424S702000
Reexamination Certificate
active
06939893
ABSTRACT:
The present invention discloses a method for enhancing the efficacy of anti-cancer agents. The method comprises administering to an individual, in need of such a treatment, an anti-cancer agent and a selenium compound. The selenium compounds may be administered before, during or after administration of the anti-cancer agent.
REFERENCES:
patent: 4617189 (1986-10-01), Stockel et al.
patent: 5552440 (1996-09-01), Crooks et al.
patent: 6197295 (2001-03-01), Hsia et al.
Vadgama J et al, Anticancer Res 20:1391-1414, 2000.
Chen D et al, J Trace Elements in Exper Med 10:163-171, 1997.
MEDLINE AN 96356155, Boucher et al, Nutrition, Sep.-Oct. 1995, 11 (5 Suppl), 708-11, abstract.
CAPLUS 134:146813, Sieja, Pharmazie, 2000, 55(12), 958-959, abstract.
EMBASE 2001377446, Frenkel, Current Pharmaceutical Design, 2001, 7/16, 1595-1614, abstract.
Dong et al.,Identification of Molecular Targets Associated with Selenium-Induced Growth Inhibition in Human Breast Cells Uing cDNA Microarrays, Cancer Research, Feb. 1, 2002, vol. 62, pp. 708-714.
El-Bayoumy et al.,The Protective Role of Selenium on Genetic Damage and on Cancer, Mutation Research, 2001, vol. 475, pp. 123-129.
Hu et al.,The Protective Role of Selenium on the Toxicity of Cisplatin-Contained Chemotherapy Regimen in Cancer Patients, Biological Trace Element Research, 1997, vol. 56, pp. 331-341.
Kajander et al.,Effects of Selenomethionine Metabolism in Cultured Malignant Cells, Biochem. J., 1990, vol. 267, pp. 767-774.
Ohkawa et al.,The Effects of Co-Administration of Selenium and Cis-platin(CDDP)on CDDP-Induced Toxicity and Antitumor Activity, Br. J. Cancer, 1988, vol. 58, pp. 34-41.
Seo et al.,Selenomethionine Regulation of p53 by a Refl-Dependent Redox Mechanism, PNAS, Oct. 29, 2002, vol. 99, No. 22, pp. 14548-14553.
Wang et al.,Induction of Caspase-Mediated Apoptosis and Cell-Cycle G1Arrest by Selenium Metabolite Methylselenol, Molecular Carcinogenesis, 2002, vol. 34, pp. 113-120.
Konorev et al.,Cell-Permeable Superoxide Dismutase and Glutahione Peroxidase Mimetics Afford Superior Protection Against Doxorubucin-Induced Cardiotoxicity: The Role of Reactive Oxygen and Nitrogen Intermediates, Archives Biochem. Biophysics, 1999, 368 (2) pp. 421-428, abstract.
Korbac et al.,Doxorubicin Toxicity to the Skin: Possibility of Protection with Antioxidants Enriched Yeast, J. Dermat. Sci., 2001, 25 (1) pp. 45-52, abstract.
Chen et al.,Protective Effects of Selenium Supplementation in Minimizing 5-Glorouracil Induced Lipid Peroxidative Damage of the Small Intestine, J. Trace Elements in Experimental Med., 1997, 10 (3) pp. 163-171, abstract.
Cao Shousong
Durrani Farukh
Rustum Youcef M.
Cook Rebecca
Health Research , Inc.
Hodgson & Russ LLP
LandOfFree
Method of reducing toxicity of anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing toxicity of anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing toxicity of anticancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3400942